SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-067144
Filing Date
2018-03-01
Accepted
2018-03-01 16:11:09
Documents
72
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d518852d10k.htm 10-K 1004568
2 EX-10.8 d518852dex108.htm EX-10.8 63270
3 EX-10.14 d518852dex1014.htm EX-10.14 35764
4 EX-10.20 d518852dex1020.htm EX-10.20 20703
5 EX-23.1 d518852dex231.htm EX-23.1 3659
6 EX-31.1 d518852dex311.htm EX-31.1 6911
7 EX-31.2 d518852dex312.htm EX-31.2 7048
8 EX-32.1 d518852dex321.htm EX-32.1 4573
15 GRAPHIC g518852g92h97.jpg GRAPHIC 129518
  Complete submission text file 0001193125-18-067144.txt   5033062

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT itci-20171231.xml EX-101.INS 864492
10 XBRL TAXONOMY EXTENSION SCHEMA itci-20171231.xsd EX-101.SCH 45820
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20171231_cal.xml EX-101.CAL 71267
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20171231_def.xml EX-101.DEF 161925
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20171231_lab.xml EX-101.LAB 420162
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20171231_pre.xml EX-101.PRE 306569
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36274 | Film No.: 18657380
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences